Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography
Title: | Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography |
---|---|
Authors: | Ludhmila Abrahão Hajjar, Marco B. Ancona, Roberto Kalil Filho, Moreno Tresoldi, José Guilherme Caldas, Giacomo Monti, Francisco Cesar Carnevale, Francesco De Cobelli, André Moreira de Assis, Fabio Ciceri, Giovanni Landoni, Jouke Dijkstra, Francesco Moroni, Alexandre Antônio Cunha Abizaid, Fernanda Willemann Ungaretti, Maria José Carvalho Carmona, Daniel De Backer, Carlos Eduardo Pompilio, Fábio S. de Britto, Carlos M. Campos, Alberto Zangrillo, Matteo Montorfano |
Source: | Frontiers in Medicine, Vol 10 (2023) |
Publisher Information: | Frontiers Media S.A., 2023. |
Publication Year: | 2023 |
Collection: | LCC:Medicine (General) |
Subject Terms: | COVID-19, MicroClots, OCT, thrombo-inflammatory syndrome, D-dimer, Medicine (General), R5-920 |
More Details: | BackgroundMicrovascular lung vessels obstructive thromboinflammatory syndrome has been proposed as a possible mechanism of respiratory failure in COVID-19 patients. However, it has only been observed in post-mortem studies and has never been documented in vivo, probably because of a lack of CT scan sensitivity in small pulmonary arteries. The aim of the present study was to assess the safety, tolerability, and diagnostic value of optical coherence tomography (OCT) for the assessment of patients with COVID-19 pneumonia for pulmonary microvascular thromboinflammatory syndrome.MethodsThe COVID-OCT trial was a multicenter, open-label, prospective, interventional clinical study. Two cohorts of patients were included in the study and underwent pulmonary OCT evaluation. Cohort A consisted of patients with COVID-19 with a negative CT scan for pulmonary thrombosis and elevated thromboinflammatory markers (D-dimer > 10,000 ng/mL or 5,000 < D-dimer < 10,000 ng/mL and one of: C-reactive Protein > 100 mg/dL, IL-6 > 6 pg/mL, or ferritin > 900 ng/L). Cohort B consisted of patients with COVID-19 and a CT scan positive for pulmonary thrombosis. The primary endpoints of the study were: (i) to evaluate the overall safety of OCT investigation in patients with COVID-19 pneumonia, and (ii) to report on the potential value of OCT as a novel diagnostic tool for the diagnosis of microvascular pulmonary thrombosis in COVID-19 patients.ResultsA total of 13 patients were enrolled. The mean number of OCT runs performed in each patient was 6.1 ± 2.0, both in ground glass and healthy lung areas, achieving a good evaluation of the distal pulmonary arteries. Overall, OCT runs identified microvascular thrombosis in 8 patients (61.5%): 5 cases of red thrombus, 1 case of white thrombus, and 2 cases of mixed thrombus. In Cohort A, the minimal lumen area was 3.5 ± 4.6 mm2, with stenosis of 60.9 ± 35.9% of the area, and the mean length of thrombus-containing lesions was 5.4 ± 3.0 mm. In Cohort B, the percentage area obstruction was 92.6 ± 2.6, and the mean thrombus-containing lesion length was 14.1 ± 13.9 mm. No peri-procedural complications occurred in any of the 13 patients.ConclusionOCT appears to be a safe and accurate method of evaluating the distal pulmonary arteries in hospitalized COVID-19 patients. Here, it enabled the first in vivo documentation of distal pulmonary arterial thrombosis in patients with elevated thromboinflammatory markers, even when their CT angiogram was negative for pulmonary thrombosis.Clinical trial registrationClinicalTrial.gov, identifier NCT04410549. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2296-858X |
Relation: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1050531/full; https://doaj.org/toc/2296-858X |
DOI: | 10.3389/fmed.2023.1050531 |
Access URL: | https://doaj.org/article/45626f662095495e965257f4d9da4336 |
Accession Number: | edsdoj.45626f662095495e965257f4d9da4336 |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=2296858X&ISBN=&volume=10&issue=&date=20230201&spage=&pages=&title=Frontiers in Medicine&atitle=Microvascular%20lung%20vessels%20obstructive%20thromboinflammatory%20syndrome%20in%20patients%20with%20COVID-19%3A%20Insights%20from%20lung%20intravascular%20optical%20coherence%20tomography&aulast=Ludhmila%20Abrah%C3%A3o%20Hajjar&id=DOI:10.3389/fmed.2023.1050531 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/45626f662095495e965257f4d9da4336 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.45626f662095495e965257f4d9da4336 RelevancyScore: 961 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 960.989685058594 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ludhmila+Abrahão+Hajjar%22">Ludhmila Abrahão Hajjar</searchLink><br /><searchLink fieldCode="AR" term="%22Marco+B%2E+Ancona%22">Marco B. Ancona</searchLink><br /><searchLink fieldCode="AR" term="%22Roberto+Kalil+Filho%22">Roberto Kalil Filho</searchLink><br /><searchLink fieldCode="AR" term="%22Moreno+Tresoldi%22">Moreno Tresoldi</searchLink><br /><searchLink fieldCode="AR" term="%22José+Guilherme+Caldas%22">José Guilherme Caldas</searchLink><br /><searchLink fieldCode="AR" term="%22Giacomo+Monti%22">Giacomo Monti</searchLink><br /><searchLink fieldCode="AR" term="%22Francisco+Cesar+Carnevale%22">Francisco Cesar Carnevale</searchLink><br /><searchLink fieldCode="AR" term="%22Francesco+De+Cobelli%22">Francesco De Cobelli</searchLink><br /><searchLink fieldCode="AR" term="%22André+Moreira+de+Assis%22">André Moreira de Assis</searchLink><br /><searchLink fieldCode="AR" term="%22Fabio+Ciceri%22">Fabio Ciceri</searchLink><br /><searchLink fieldCode="AR" term="%22Giovanni+Landoni%22">Giovanni Landoni</searchLink><br /><searchLink fieldCode="AR" term="%22Jouke+Dijkstra%22">Jouke Dijkstra</searchLink><br /><searchLink fieldCode="AR" term="%22Francesco+Moroni%22">Francesco Moroni</searchLink><br /><searchLink fieldCode="AR" term="%22Alexandre+Antônio+Cunha+Abizaid%22">Alexandre Antônio Cunha Abizaid</searchLink><br /><searchLink fieldCode="AR" term="%22Fernanda+Willemann+Ungaretti%22">Fernanda Willemann Ungaretti</searchLink><br /><searchLink fieldCode="AR" term="%22Maria+José+Carvalho+Carmona%22">Maria José Carvalho Carmona</searchLink><br /><searchLink fieldCode="AR" term="%22Daniel+De+Backer%22">Daniel De Backer</searchLink><br /><searchLink fieldCode="AR" term="%22Carlos+Eduardo+Pompilio%22">Carlos Eduardo Pompilio</searchLink><br /><searchLink fieldCode="AR" term="%22Fábio+S%2E+de+Britto%22">Fábio S. de Britto</searchLink><br /><searchLink fieldCode="AR" term="%22Carlos+M%2E+Campos%22">Carlos M. Campos</searchLink><br /><searchLink fieldCode="AR" term="%22Alberto+Zangrillo%22">Alberto Zangrillo</searchLink><br /><searchLink fieldCode="AR" term="%22Matteo+Montorfano%22">Matteo Montorfano</searchLink> – Name: TitleSource Label: Source Group: Src Data: Frontiers in Medicine, Vol 10 (2023) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Frontiers Media S.A., 2023. – Name: DatePubCY Label: Publication Year Group: Date Data: 2023 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Medicine (General) – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22MicroClots%22">MicroClots</searchLink><br /><searchLink fieldCode="DE" term="%22OCT%22">OCT</searchLink><br /><searchLink fieldCode="DE" term="%22thrombo-inflammatory+syndrome%22">thrombo-inflammatory syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22D-dimer%22">D-dimer</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine+%28General%29%22">Medicine (General)</searchLink><br /><searchLink fieldCode="DE" term="%22R5-920%22">R5-920</searchLink> – Name: Abstract Label: Description Group: Ab Data: BackgroundMicrovascular lung vessels obstructive thromboinflammatory syndrome has been proposed as a possible mechanism of respiratory failure in COVID-19 patients. However, it has only been observed in post-mortem studies and has never been documented in vivo, probably because of a lack of CT scan sensitivity in small pulmonary arteries. The aim of the present study was to assess the safety, tolerability, and diagnostic value of optical coherence tomography (OCT) for the assessment of patients with COVID-19 pneumonia for pulmonary microvascular thromboinflammatory syndrome.MethodsThe COVID-OCT trial was a multicenter, open-label, prospective, interventional clinical study. Two cohorts of patients were included in the study and underwent pulmonary OCT evaluation. Cohort A consisted of patients with COVID-19 with a negative CT scan for pulmonary thrombosis and elevated thromboinflammatory markers (D-dimer > 10,000 ng/mL or 5,000 < D-dimer < 10,000 ng/mL and one of: C-reactive Protein > 100 mg/dL, IL-6 > 6 pg/mL, or ferritin > 900 ng/L). Cohort B consisted of patients with COVID-19 and a CT scan positive for pulmonary thrombosis. The primary endpoints of the study were: (i) to evaluate the overall safety of OCT investigation in patients with COVID-19 pneumonia, and (ii) to report on the potential value of OCT as a novel diagnostic tool for the diagnosis of microvascular pulmonary thrombosis in COVID-19 patients.ResultsA total of 13 patients were enrolled. The mean number of OCT runs performed in each patient was 6.1 ± 2.0, both in ground glass and healthy lung areas, achieving a good evaluation of the distal pulmonary arteries. Overall, OCT runs identified microvascular thrombosis in 8 patients (61.5%): 5 cases of red thrombus, 1 case of white thrombus, and 2 cases of mixed thrombus. In Cohort A, the minimal lumen area was 3.5 ± 4.6 mm2, with stenosis of 60.9 ± 35.9% of the area, and the mean length of thrombus-containing lesions was 5.4 ± 3.0 mm. In Cohort B, the percentage area obstruction was 92.6 ± 2.6, and the mean thrombus-containing lesion length was 14.1 ± 13.9 mm. No peri-procedural complications occurred in any of the 13 patients.ConclusionOCT appears to be a safe and accurate method of evaluating the distal pulmonary arteries in hospitalized COVID-19 patients. Here, it enabled the first in vivo documentation of distal pulmonary arterial thrombosis in patients with elevated thromboinflammatory markers, even when their CT angiogram was negative for pulmonary thrombosis.Clinical trial registrationClinicalTrial.gov, identifier NCT04410549. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2296-858X – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://www.frontiersin.org/articles/10.3389/fmed.2023.1050531/full; https://doaj.org/toc/2296-858X – Name: DOI Label: DOI Group: ID Data: 10.3389/fmed.2023.1050531 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/45626f662095495e965257f4d9da4336" linkWindow="_blank">https://doaj.org/article/45626f662095495e965257f4d9da4336</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.45626f662095495e965257f4d9da4336 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.45626f662095495e965257f4d9da4336 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmed.2023.1050531 Languages: – Text: English Subjects: – SubjectFull: COVID-19 Type: general – SubjectFull: MicroClots Type: general – SubjectFull: OCT Type: general – SubjectFull: thrombo-inflammatory syndrome Type: general – SubjectFull: D-dimer Type: general – SubjectFull: Medicine (General) Type: general – SubjectFull: R5-920 Type: general Titles: – TitleFull: Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ludhmila Abrahão Hajjar – PersonEntity: Name: NameFull: Marco B. Ancona – PersonEntity: Name: NameFull: Roberto Kalil Filho – PersonEntity: Name: NameFull: Moreno Tresoldi – PersonEntity: Name: NameFull: José Guilherme Caldas – PersonEntity: Name: NameFull: Giacomo Monti – PersonEntity: Name: NameFull: Francisco Cesar Carnevale – PersonEntity: Name: NameFull: Francesco De Cobelli – PersonEntity: Name: NameFull: André Moreira de Assis – PersonEntity: Name: NameFull: Fabio Ciceri – PersonEntity: Name: NameFull: Giovanni Landoni – PersonEntity: Name: NameFull: Jouke Dijkstra – PersonEntity: Name: NameFull: Francesco Moroni – PersonEntity: Name: NameFull: Alexandre Antônio Cunha Abizaid – PersonEntity: Name: NameFull: Fernanda Willemann Ungaretti – PersonEntity: Name: NameFull: Maria José Carvalho Carmona – PersonEntity: Name: NameFull: Daniel De Backer – PersonEntity: Name: NameFull: Carlos Eduardo Pompilio – PersonEntity: Name: NameFull: Fábio S. de Britto – PersonEntity: Name: NameFull: Carlos M. Campos – PersonEntity: Name: NameFull: Alberto Zangrillo – PersonEntity: Name: NameFull: Matteo Montorfano IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2296858X Numbering: – Type: volume Value: 10 Titles: – TitleFull: Frontiers in Medicine Type: main |
ResultId | 1 |